gatifloxacin has been researched along with Rhinitis in 3 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Rhinitis: Inflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The bacteriological and clinical efficacy and the safety of gatifloxacin for the treatment of non-complicated acute rhinosinusitis was evaluated in 49 adult patients in an open-label multicenter study in Brazil." | 9.11 | An open multicenter study of the use of gatifloxacin for the treatment of non-complicated acute bacterial rhinosinusitis in adults. ( Campos, CA; Figueiredo, CR; Pignatari, SS; Sakano, E; Weckx, LL, 2005) |
| "We sought to evaluate gatifloxacin in adults with acute uncomplicated bacterial rhinosinusitis." | 9.10 | Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin. ( Nicholson, SC; Pankey, GA; Poole, MD; Sher, LD; Von Seggern, K; Wikler, MA, 2002) |
| "The bacteriological and clinical efficacy and the safety of gatifloxacin for the treatment of non-complicated acute rhinosinusitis was evaluated in 49 adult patients in an open-label multicenter study in Brazil." | 5.11 | An open multicenter study of the use of gatifloxacin for the treatment of non-complicated acute bacterial rhinosinusitis in adults. ( Campos, CA; Figueiredo, CR; Pignatari, SS; Sakano, E; Weckx, LL, 2005) |
| "We sought to evaluate gatifloxacin in adults with acute uncomplicated bacterial rhinosinusitis." | 5.10 | Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin. ( Nicholson, SC; Pankey, GA; Poole, MD; Sher, LD; Von Seggern, K; Wikler, MA, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sher, LD | 1 |
| Poole, MD | 1 |
| Von Seggern, K | 1 |
| Wikler, MA | 1 |
| Nicholson, SC | 1 |
| Pankey, GA | 1 |
| Anon, JB | 1 |
| Weckx, LL | 1 |
| Campos, CA | 1 |
| Sakano, E | 1 |
| Pignatari, SS | 1 |
| Figueiredo, CR | 1 |
1 review available for gatifloxacin and Rhinitis
| Article | Year |
|---|---|
Current management of acute bacterial rhinosinusitis and the role of moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Clinical Trials as Topic; Drug Resistanc | 2005 |
2 trials available for gatifloxacin and Rhinitis
| Article | Year |
|---|---|
Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin.
Topics: Acute Disease; Aged; Anti-Infective Agents; Bacterial Infections; Community-Acquired Infections; Dru | 2002 |
An open multicenter study of the use of gatifloxacin for the treatment of non-complicated acute bacterial rhinosinusitis in adults.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Female; Fluoroquinolones; Gatifloxaci | 2005 |